| Price | 9.25p on 23-04-2026 at 07:20:15 |
|---|---|
| Change | 0.00p 0% |
| Buy | 9.50p |
| Sell | 9.00p |
| Last Trade: | Sell 7,584.00 at 9.15p |
| Day's Volume: | 11,252 |
| Last Close: | 9.25p |
| Open: | 9.25p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.25p - 9.25p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £98.83m |
| VWAP: | 9.145467p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 7,584 | 9.15p | Ordinary |
08:14:25 - 23-Apr-26 |
| Sell* | 2,888 | 9.15p | Ordinary |
08:09:11 - 23-Apr-26 |
| Sell* | 680 | 9.075p | Ordinary |
08:04:34 - 23-Apr-26 |
| Sell* | 100 | 9.15p | Ordinary |
08:04:03 - 23-Apr-26 |
| Buy* | 5,339 | 9.27p | Ordinary |
16:24:03 - 22-Apr-26 |
| Buy* | 26 | 9.50p | SI Trade |
16:17:41 - 22-Apr-26 |
| Sell* | 30,165 | 9.16p | Ordinary |
16:17:32 - 22-Apr-26 |
| Sell* | 26 | 9.10p | SI Trade |
16:09:16 - 22-Apr-26 |
| Sell* | 8,000 | 9.16p | Ordinary |
15:27:31 - 22-Apr-26 |
| Sell* | 5,000 | 9.16p | Ordinary |
15:21:30 - 22-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
